There are six specific clinical variables that can accurately predict rapid decline among patients with autosomal dominant polycystic kidney disease (ADPKD), a researcher reported. In a study that ...
The Kidney Disease: Improving Global Outcomes (KDIGO) group has released its 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney ...
The combination of ADPKD genotype and baseline kidney size can predict rapid kidney function decline in routine clinical practice. Combining genotype and kidney length can identify nearly 9 out of 10 ...
A new study has addressed a key question in autosomal dominant polycystic kidney disease (ADPKD): can we predict renal outcome at an early disease stage? Indeed, this information is useful for any ...
Tolvaptan’s effect on total kidney volume and eGFR decline diminished with increasing visceral adiposity. Visceral adiposity independently predicts rapid kidney growth and lower tolvaptan efficacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback